Cho, H.; Shim, M.K.; Moon, Y.; Song, S.; Kim, J.; Choi, J.; Kim, J.; Lee, Y.; Park, J.Y.; Kim, Y.;
et al. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy. Pharmaceutics 2022, 14, 2131.
https://doi.org/10.3390/pharmaceutics14102131
AMA Style
Cho H, Shim MK, Moon Y, Song S, Kim J, Choi J, Kim J, Lee Y, Park JY, Kim Y,
et al. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy. Pharmaceutics. 2022; 14(10):2131.
https://doi.org/10.3390/pharmaceutics14102131
Chicago/Turabian Style
Cho, Hanhee, Man Kyu Shim, Yujeong Moon, Sukyung Song, Jinseong Kim, Jiwoong Choi, Jeongrae Kim, Youngjoo Lee, Jung Yeon Park, Yongju Kim,
and et al. 2022. "Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy" Pharmaceutics 14, no. 10: 2131.
https://doi.org/10.3390/pharmaceutics14102131
APA Style
Cho, H., Shim, M. K., Moon, Y., Song, S., Kim, J., Choi, J., Kim, J., Lee, Y., Park, J. Y., Kim, Y., Ahn, C.-H., Kim, M. R., Yoon, H. Y., & Kim, K.
(2022). Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy. Pharmaceutics, 14(10), 2131.
https://doi.org/10.3390/pharmaceutics14102131